Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
World Conference on Lung Cancer
Biotech
Amgen touts early combo data with Sanofi-backed KRAS partner
Amgen is touting early phase 1 data of its FDA-approved lung cancer treatment Lumakras in combination with a Sanofi-backed KRAS partner.
Max Bayer
Jul 12, 2022 7:30pm
J&J's bispecific curbs 74% of lung cancers with rare mutation
Jan 28, 2021 10:45pm
Amgen's KRAS drug pads its case for approval
Jan 28, 2021 4:47pm